UniQuest Pty Ltd

UniQuest Pty Ltd is developing a novel, exciting first-class oral therapy for the treatment of prostate cancer. The company's candidate drug has demonstrated significant anti-tumor activity in prostate cancer models, comparable to the current standard of care.